Scientists believe that for the first time, they have linked the gene CUX1 to the development of one in every 100 tumors in cancer patients.
FierceBiotech is now available on iPhone and iPad!
This is the best FierceBiotech reading experience we've ever created. Swipe right-to-left within articles to quickly scan the latest news. Get breaking news alerts sent to your mobile device so you're the first to know when a major story unfolds. Download it today; the app is an essential complement to our e-mail newsletter and website.
Android users: We're on track to have an app complete by the end of the year.
Needless to say, both humans and preclinical studies have limitations--we can't spot every error, and there's only so much a mouse model can tell us. But that doesn't mean basic science research and preclinical studies are useless or even irrelevant. What it means is that we have to take new studies with a grain of salt. Scientists know that early research in peer-reviewed literature is largely speculative and exploratory. The challenge for those of us covering this research is sifting through all the releases touting new "scientific breakthroughs" and putting animal studies in context for readers.
Looking over the past year, FierceBiotech Research has put together a report on 5 promising preclinical programs.
Have something to say? Join the conversation at
FierceBiotech's LinkedIn group.
POPULAR COMMENT THREADS
The medical community welcomed a budget deal struck Tuesday night by the U.S. Congress, which, if approved, would restore funding to the National Institutes of Health, among other federal programs, that had been slashed under sequestration earlier this year.
Early research published in peer-reviewed journals is exploratory and largely speculative. But when results from these studies can't be reproduced, science comes under fire. Now a new report suggests that a unifying standards framework could yield more credible scientific results.
International Stem Cell Corp. has found a new way to genetically reprogram mature cells into an embryonic-like state, a technique the Carlsbad, CA-based company believes is a safer and more efficient way of creating induced pluripotent stem cells.
A gene discovery by researchers at Tel Aviv University may predict which people are likely to benefit from commonly prescribed antidepressants known as selective serotonin reuptake inhibitors.
With resistance to first-line malaria drugs and the emergence of an especially severe form of malaria on the rise, more investment in early science is needed to combat the disease, according to a new report.
GlaxoSmithKline is launching what it calls the Oncology Clinical and Translational Consortium, a collaborative scientific research network intended to advance drug discovery that will include 6 cancer centers around the world.
From Our Sister Sites
The suspicion that some ineffective vaccines are administered in the U.K. stems from inspection reports written by the independent health services regulator. Having inspected 1,000 healthcare practices since April, the Care Quality Commission (CQC) highlighted vaccines as a problem area for some sites.
Colorado startup Sundance Diagnostics said it will work with Germany's famed Max Planck Institute of Psychiatry to develop and commercialize a diagnostic blood test that would gauge suicide risk for patients taking antidepressants.